Cellular mechanisms of thyroid hormone action;Mécanismes d'action cellulaire des hormones thyroïdiennes

Presse Medicale

Volumn 34, Issue 16 I, 2005, Pages 1147-1152

  Vinzio, Stéphane ^a   Morel, O ^a   Schlienger, J L ^a   Goichot, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIOTHYRONINE; MEMBRANE RECEPTOR; MYOSIN HEAVY CHAIN; THYROID HORMONE;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVITY; GENE TARGETING; HEART MUSCLE CELL; HYPERTHYROIDISM; PROTEIN SYNTHESIS; REVIEW; SINUS NODE; THYROID FUNCTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 25444455401     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)84141-7     Document Type: Short Survey

References (35)

1. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89.
2. Bassett JH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003; 213: 1-11.
3. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 2003; 14: 85-90.
4. Brent GA. Tissue-specific actions of thyroid hormone: insights from animal models. Rev Endocr Metab Disord 2000; 1: 27-33.
5. Lazar MA. Thyroid hormone action: a binding contract. J Clin Invest 2003; 112: 497-9.
6. Feng X, Jiang Y, Meltzer P, Yen PM. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 2000; 14: 947-55.
7. Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol 2004; 5: R31.
8. Kavok NS, Krasilnikova OA, Babenko NA. Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol 2001; 2: 5.
9. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ et al. 3-lodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004; 10: 638-42.
10. Liggett SB. The two-timing thyroid. Nat Med 2004; 10: 582-3.
11. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-9.
12. Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31-50.
13. Everts ME, Verhoeven FA, Bezstarosti K, Moerings EP, Hennemann G, Visser TJ et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology 1996; 137: 4235-42.
14. Ladenson PW, Sherman SI, Baughman KL, Ray PE, Feldman AM. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 1992; 89: 5251-5.
15. Carr AN, Kranias EG. Thyroid hormone regulation of calcium cycling proteins. Thyroid 2002; 12: 453-7.
16. 2+ transport and myocardial relaxation. Circ Res 1994; 75: 245-51.
17. Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res 1998; 83: 608-13.
18. Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions. J Mol Cell Cardiol 1999; 31: 1725-37.
19. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone on the heart. Thyroid 2002; 12: 459-66
20. et 1992; 33: 1132-6.
21. Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA. Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 2001; 33: 811-24.
22. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M et al. Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 1995; 211: 426-31.
23. Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D et al. Cardiomyopathy associated with Graves' disease. Clin Endocrinol (Oxf) 1996; 45: 111-16.
24. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990; 88: 642-6.
25. Hoit BD, Khoury SF, Shao Y, Gabel M, Liggett SB, Walsh RA. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation 1997; 96: 592-8.
26. Ojamaa K, Klein I, Sabet A, Steinberg SF. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism 2000; 49: 275-9.
27. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 2002; 12: 447-52.
28. Carvalho-Bianco SD, Kim BW, Zhang JX, Harney JW, Ribeiro RS, Gereben B et al. Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. Mol Endocrinol 2004; 18: 1840-9.
29. Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996; 6: 505-12.
30. Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Anal 1997; 85: 734-8.
31. Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, Masuda S et al. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 2003; 41: 598-603.
32. Diekman MJ, Harms MP, Endert E, Wieling W, Wiersinga WM. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur J Endocrinol 2001; 144: 339-46.
33. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 2001; 104: 3076-80.
34. Resnick LM, Laragh JH. Plasma renin activity in syndromes of thyroid hormone excess and deficiency. Life Sci 1982; 30: 585-6.
35. Klein I, Levey GS. New perspectives on thyroid hormone, catecholamines, and the heart. Am J Med 1984; 76: 167-72.